Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD0780 Effect on Metformin PK in Healthy Volunteers
NCT07216131Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of laroprovstat in hypercholesterolemia, sponsored by AstraZeneca. Primary endpoints: Area under concentration time curve from time 0 to infinity, Area under concentration curve from time 0 to the last quantifiable concentration and 1 more. Started Nov 2025; status: completed.
02
Drugs
laroprovstat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT07216131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07216131.